HONG KONG DRUG LICENSING
Hong Kong Drug Licence FAQs
Search 500 Hong Kong drug licence FAQs on applications, personnel, premises, quality systems, ongoing regulation, renewals and acquisitions.
Information status: The original FAQ material dates from 2025 and is provided for topic-based reference; it does not represent an individual verification of all 500 FAQs against current rules. For application, fee, renewal, change, product or prescription requirements, please refer to the current official forms and guidance.
Official information from the Drug Office Official information from the Chinese Medicines Board
找到 500 条结果，第 14／25 页。每页显示 20 条；无需启用 JavaScript。
Q261 · 总体来看，从零开始设立一家符合标准的西药批发商，我应该准备多少启动资金？独立链接
Establishing a compliant wholesaler of Western medicines is a substantial capital investment. In our experience, a comprehensive start-up budget should cover the following core areas. First, premises costs, including at least 3 months’ rental deposit and rent in advance, as well as basic fitting-out costs. Second, compliance system establishment, including a complete set of pharmaceutical manufacturing quality management (QMS) documents, temperature and humidity monitoring and recording equipment, and installation of security systems. Third, professional service fees payable to consultancy firms such as ours. Finally, and most importantly, working capital: you need to reserve at least 6–9 months of operating funds to pay staff salaries, rent, utilities and purchases of the initial stock of medicines. Overall, we recommend preparing at least HKD 1,500,000 to HKD 3,000,000 in start-up capital for a small or medium-sized wholesaler of Western medicines.
Q262 · 如何有效控制药品业务的运营成本，同时又不牺牲合规性？独立链接
In the pharmaceutical industry, cost control does not mean compromising on compliance; it means spending wisely. Effective strategies include: 1. “Optimise inventory management” by applying the first-in, first-out (FIFO) or first-expired, first-out (FEFO) principle and using software to forecast demand accurately, reducing losses from expired pharmaceutical products. 2. “Reduce energy consumption” by investing in energy-efficient air-conditioning and refrigeration equipment, which can save substantial electricity costs over the long term. 3. “Automate processes” by introducing automation tools for order processing, warehouse management and other operations to improve efficiency and reduce human error. 4. “Manage suppliers” by building good relationships with multiple suppliers and seeking better prices through bulk purchasing or long-term contracts, provided that all suppliers are legally licensed.
Q263 · 申请牌照过程中，如果需要对场地进行改造，这部分的工程费用应该如何预估？独立链接
Premises renovation costs are one variable in start-up costs, and depend on the gap between the property’s original condition and the requirements of the target licence. Estimates should take account of the following key items: 1. “Heating, ventilation and air-conditioning system (HVAC)”: a separate commercial air-conditioning system may need to be installed or upgraded to meet temperature and humidity control requirements. 2. “Partitions and layout”: walls or partitions may need to be built or installed to provide functional areas (such as receiving, storage, dispensing and office areas). 3. “Power and lighting”: ensure adequate electrical load and compliant lighting. 4. “Security facilities”: including CCTV, burglar alarms and cabinets for storing hazardous materials. 5. “Floors and walls”: seamless, easy-to-clean epoxy flooring may need to be installed. Renovation costs for a small or medium-sized pharmacy or warehouse may range from tens of thousands to hundreds of thousands of Hong Kong dollars.
Q264 · 对于中成药制造商，建立一个符合GMP标准的厂房，其投资回报周期大概是多久？独立链接
Establishing a Chinese medicine factory that complies with Good Manufacturing Practice (GMP) is a long-term strategic investment. The payback period cannot be generalised, but is usually measured in years. Its length depends on several changing factors: 1. “Product portfolio and market positioning”: whether your medicines have exclusive patents, strong brand appeal or clear market demand. 2. “Sales channels and network”: whether you have an effective distribution network to bring products to market quickly. 3. “Production efficiency and cost control”: the level of production-line automation, yield and raw-material purchasing costs directly affect profit margins. 4. “Pricing strategy”: whether product prices can generate sufficient returns after covering high fixed-asset depreciation and operating costs.
Q265 · 除了政府费用，在香港经营药品业务还需要向哪些第三方机构支付强制性或必要的费用？独立链接
In addition to licence fees paid directly to the government, operating a pharmaceutical business in Hong Kong involves a range of compulsory or business-essential third-party costs. These mainly include: 1. “Insurance”: you must take out employees’ compensation insurance as required by the Employees’ Compensation Ordinance. Public liability and property insurance are also strongly recommended to manage risk. 2. “Annual fees for professional bodies”: if your pharmacist is a member of a professional body such as the Pharmaceutical Society of Hong Kong, an annual fee may be payable to maintain their professional membership. 3. “Waste disposal fees”: expired or non-conforming medicines must be handled by a licensed clinical waste collector, creating an ongoing operating expense. 4. “Audit and tax filing fees”: you need to engage a practising accountant to carry out the company’s annual audit and submit its tax returns.
Q266 · 我的药品批发业务年营业额预计在500万港元，那么我的年度合规维护成本大概是多少？独立链接
Annual ongoing compliance costs do not have a direct linear relationship with turnover; they depend more on the complexity of your business and the professional capabilities of your internal team. These costs mainly include: 1. Licence renewal fees, which are fixed annual fees paid to the government. 2. Quality Management System (QMS) maintenance costs, which may include engaging external consultants for annual audits, document updates and internal training. 3. Continuing Professional Development (CPD) costs for mandatory in-service training for your pharmacist or other key personnel. 4. Equipment calibration and validation costs, for items such as temperature and humidity meters and refrigerated cabinets requiring regular calibration by recognised organisations. 5. External audit and legal advisory fees. For a small or medium-sized wholesaler with annual turnover of HKD 5,000,000 and no dedicated internal compliance manager, we estimate that annual ongoing compliance costs may range from HKD 50,000 to HKD 150,000.
Q267 · 如果我的牌照申请被拒绝，已投入的资金，例如装修费和顾问费，能退回吗？独立链接
This is a very realistic and sobering question. If your licence application is formally refused by the regulator, most of the funds already invested cannot be recovered. Specifically: 1. “Government application fees” are expressly non-refundable. 2. “Premises rent and fitting-out costs” are governed by your commercial contracts with the landlord and contractor and are unrelated to the outcome of the licence application; the money spent is essentially a sunk cost. 3. “Equipment purchase costs”: equipment already purchased may be resold at a discount, but losses are inevitable. 4. “Professional consultancy fees” depend on the terms of your contract with the consultancy firm. Rengangyongsheng (Hong Kong) Limited’s contracts clearly set out service fees at each stage, but fees for services already completed are generally not refunded if an application fails.
Q268 · 在财务规划上，我应该如何为“不可预见的监管变化”预留预算？独立链接
Setting aside a budget for “unforeseeable regulatory changes” reflects sound financial planning. As medicine safety affects public health, the relevant laws and standards are continually updated and tightened. We recommend the following strategies: 1. “Establish a compliance contingency fund”: in addition to routine operating costs, set aside a specific amount in your annual budget, for example 1-2% of annual profit, specifically to meet additional expenses arising from regulatory changes. 2. “Purchase appropriate professional indemnity insurance”: some insurance products may cover business interruption or additional expenditure resulting from regulatory changes. 3. “Stay informed”: maintaining a long-term relationship with a specialist consultancy such as ours will help you receive regulatory updates promptly and prepare in advance, minimising the impact of “unforeseeable” changes.
Q269 · 申请“列载毒药销售商”牌照的成本与申请“药房”牌照相比如何？独立链接
The cost of applying for a “Listed Seller of Poisons” (LSP) licence is usually much lower than that of applying for an “Authorised Seller of Poisons” (Pharmacy) licence. The main differences are: 1. “Government fees”: the LSP application fee and annual fee (currently HKD$455) are significantly lower than those for a pharmacy. 2. “Staffing requirements”: an LSP does not need to employ a full-time registered pharmacist; it only needs to ensure that staff have completed a training course recognised by the Pharmacy and Poisons Board (PPB), substantially reducing staffing costs. 3. “Premises requirements”: although the relevant medicines must be stored securely, the fit-out and layout requirements are not as stringent as those for a pharmacy, and a dedicated dispensing area is not required. It is therefore often an option for convenience stores, supermarkets or dispensaries selling non-prescription medicines.
Q270 · 如果我通过收购一家现有持牌公司来进入市场，其财务成本与从零申请相比如何？独立链接
Acquiring an existing licensed company is a common ‘capital in exchange for time’ strategy, and its financial costs differ considerably from applying from scratch. The main acquisition cost is the ‘share transfer price’, which is usually much higher than the start-up capital required for a new business because it includes the value of the licence-holding company, goodwill in the existing business, its customer network and staff team, and potentially its inventory. By contrast, applying from scratch mainly involves capital expenditure. The advantage of an acquisition is that operations can begin immediately, avoiding the long application and waiting periods. The drawbacks are a large upfront lump-sum investment and the need to conduct thorough due diligence on the target company.
Q271 · 为支持药品业务的启动和运营，我可以从哪些渠道寻求融资？银行贷款的难度大吗？独立链接
There are several ways to finance your pharmaceutical business: 1. “Personal funds and investment from family and friends”: this is the most common way to get started, but roles and responsibilities should be clearly defined. 2. “Commercial bank loans”: you can apply to a bank for an SME loan or commercial loan. 3. “Government funding schemes”: the Hong Kong Government offers various funding schemes for technology and SMEs, some of which may be relevant to your business. 4. “Private equity or venture capital”: if your project is distinctive and has high growth potential, it may attract professional investors. Bank loans are relatively difficult to obtain because the pharmaceutical industry is specialised and heavily regulated, so banks are very cautious when assessing applications. They will need to see a highly professional and detailed business plan, as well as evidence that your team has the expertise to operate the business.
Q272 · 作为一家持牌药品公司，在财务报告方面有什么特殊要求吗？独立链接
As a limited company registered in Hong Kong, you must first comply with the basic requirements of the Companies Ordinance: appoint a Hong Kong practising accountant each year to audit the company's financial statements, and submit the audit report and profits tax return to the Inland Revenue Department. Although there are no additional statutory format requirements for the routine financial reporting of pharmaceutical licence holders, in practice and during regulatory inspections your financial records must clearly support your compliance. For example, your purchasing records must trace each batch of medicines to its lawful source and cost; sales records must be clear; and stocktake records must reconcile with the inventory value in your financial statements.
Q273 · 在我的预算中，应该为市场推广和业务发展预留多少比例的资金？独立链接
The proportion of your budget allocated to marketing and business development depends on your business model. For a licensed pharmacy selling directly to consumers, marketing is essential. Initially, you may need to invest 10% to 20% of projected annual revenue in areas such as brand building, community outreach and online promotion. For a pharmaceutical wholesaler that mainly conducts B2B business, the proportion may be lower, around 3% to 5%, with a focus on building relationships with hospitals, clinics and pharmacy chains. The costs would mainly cover building a sales team, attending industry exhibitions and maintaining customer relationships. A manufacturer of proprietary Chinese medicines will need to invest more in brand building and educating doctors.
Q274 · 如果我的业务涉及从海外进口药品，如何管理汇率波动带来的财务风险？独立链接
For wholesalers needing to import medicines from overseas (such as Europe, the US or Japan), managing foreign exchange risk is an important part of financial planning. Sharp exchange-rate fluctuations can directly affect procurement costs and profit margins. Effective strategies include: 1. “Use forward foreign exchange contracts”: enter into a contract with a bank to lock in the exchange rate for purchasing foreign currency at a future date, thereby fixing costs. 2. “Open multi-currency accounts”: hold a certain amount of commonly used foreign currencies (such as US dollars or euros), buying them when exchange rates are favourable for future payments. 3. “Negotiate pricing terms with suppliers”: try to include a clause in the purchase contract allocating the impact of exchange-rate fluctuations, or seek to agree prices in a relatively stable currency such as Hong Kong dollars or US dollars.
Q275 · 在香港经营药品业务，主要的税务责任是什么？利润税率是多少？独立链接
The principal tax obligation for operating a pharmaceutical business in Hong Kong is profits tax. Under Hong Kong’s two-tiered profits tax rates, the first HKD 2,000,000 of assessable profits of a limited company is taxed at 8.25%, while profits exceeding HKD 2,000,000 are taxed at the standard rate of 16.5%. You must submit financial statements audited by a practising accountant and a profits tax return to the Inland Revenue Department within the prescribed period after the end of each year of assessment. In addition, as an employer, you must report employees’ remuneration and withhold tax from payments to certain non-resident service providers.
Q276 · 我应该如何计算和评估我的药品业务的投资回报率（ROI）？独立链接
Calculating and assessing the return on investment (ROI) for a pharmaceutical business is key to measuring the success of your investment. The basic formula is: ROI = (annual net profit / total investment cost) x 100%. ‘Annual net profit’ is your annual total income after deducting all operating costs, including the cost of goods, rent, salaries and taxes. ‘Total investment cost’ is the total amount of funds invested in starting and operating the business, including licence applications, renovations, equipment, consultancy fees and initial working capital. A healthy pharmaceutical business should have an ROI significantly higher than a risk-free return (such as the interest rate on bank deposits) to compensate for the business risks you take and the effort you invest.
Q277 · 如果未来我想在香港开设分店或扩大仓库规模，在财务上需要做哪些准备？独立链接
Business expansion is exciting, but it must be built on a sound financial foundation. If you plan to open a branch or expand your warehouse, financial preparation is a priority: 1. “Evidence of profitability”: your existing business should already be consistently profitable and generate sufficiently strong positive cash flow. This gives you the financial confidence to expand. 2. “Dedicated expansion budget”: prepare a separate, detailed start-up budget for the new branch or warehouse, similar to the one for your original start-up and covering rent, renovation, staffing and new inventory. 3. “Financing plan”: identify the source of funding for the expansion—whether retained company profits, new bank loans or shareholder contributions. 4. “Risk assessment”: analyse the new risks that expansion may bring and ensure that you have sufficient reserves to cover any initial losses.
Q278 · 近年来监管机构对药品“追溯”要求日益严格，实施一套电子化的追溯系统大概需要多少预算？独立链接
The budget for implementing an electronic pharmaceutical track-and-trace system varies greatly, depending on the system’s complexity and the scale of your business. A basic system may simply add batch management and serial number scanning to your existing inventory management (ERP) software; this software upgrade may cost tens of thousands of Hong Kong dollars. A more comprehensive system, if it needs to comply with the international GS1 standard, use two-dimensional barcodes (Data Matrix) and establish a data exchange platform with upstream and downstream partners, may involve initial software development, hardware purchases (such as high-speed scanners and servers) and systems integration costing hundreds of thousands or even over a million Hong Kong dollars.
Q279 · 我的财务预算中，是否需要为可能发生的产品召回（Product Recall）事件预留资金？独立链接
Yes, your financial budget and risk-management plan must make provision for resources in the event of a product recall. Although you do not necessarily need to set aside a specific “recall fund”, you must ensure that your financial position is sufficiently flexible to cope with one. A product recall can give rise to a range of direct and indirect costs: 1. “Logistics and reverse logistics costs”, namely the costs of retrieving and transporting affected products. 2. “Disposal costs”, for the safe destruction of recalled products. 3. “Replacement or refund costs”, for providing replacement products or refunds to customers. 4. “Communication costs”, for issuing notices to the public, customers and regulatory authorities. 5. “Loss of goodwill”, which is the most difficult cost to quantify but may be the most serious.
Q280 · 申请中成药注册（pCm）的费用大概是多少？这与申请牌照有何不同？独立链接
The fees for applying for “proprietary Chinese medicine registration” (Proprietary Chinese Medicine Registration, pCm) are entirely different from the costs of applying for an operating licence. A licence (such as a wholesale or retail licence) authorises business activities at premises, whereas proprietary Chinese medicine registration is a market authorisation for an individual product. The statutory fee for an application for one proprietary Chinese medicine registration is HKD 9,290. This is only the government fee; the actual cost is much higher. A range of tests and studies must be conducted on the product to demonstrate its safety, quality and efficacy, including, but not limited to, tests for heavy metals and toxic elements, pesticide residues, microbial limits and stability. These tests may cost tens of thousands or even hundreds of thousands of Hong Kong dollars.